Morgan Stanley’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-565,941
Closed -$85.6M 8204
2022
Q3
$85.6M Buy
565,941
+375,508
+197% +$56.8M 0.01% 985
2022
Q2
$27.7M Buy
190,433
+87,881
+86% +$12.8M ﹤0.01% 1928
2022
Q1
$12.2M Buy
102,552
+19,949
+24% +$2.37M ﹤0.01% 2679
2021
Q4
$11.4M Buy
82,603
+40,245
+95% +$5.55M ﹤0.01% 2808
2021
Q3
$5.88M Sell
42,358
-11,311
-21% -$1.57M ﹤0.01% 3503
2021
Q2
$5.21M Buy
53,669
+12,560
+31% +$1.22M ﹤0.01% 3738
2021
Q1
$2.81M Sell
41,109
-100,556
-71% -$6.87M ﹤0.01% 3987
2020
Q4
$12.1M Buy
141,665
+91,018
+180% +$7.8M ﹤0.01% 2302
2020
Q3
$3.29M Sell
50,647
-30,819
-38% -$2M ﹤0.01% 3148
2020
Q2
$5.96M Buy
81,466
+24,410
+43% +$1.78M ﹤0.01% 2485
2020
Q1
$1.94M Sell
57,056
-18,605
-25% -$633K ﹤0.01% 3396
2019
Q4
$4.12M Buy
75,661
+681
+0.9% +$37.1K ﹤0.01% 3408
2019
Q3
$3.13M Sell
74,980
-18,882
-20% -$788K ﹤0.01% 3372
2019
Q2
$4.11M Buy
93,862
+14,539
+18% +$637K ﹤0.01% 3115
2019
Q1
$4.08M Buy
79,323
+32,617
+70% +$1.68M ﹤0.01% 2900
2018
Q4
$1.73M Sell
46,706
-55,648
-54% -$2.06M ﹤0.01% 3885
2018
Q3
$3.84M Sell
102,354
-141,996
-58% -$5.33M ﹤0.01% 3461
2018
Q2
$9.66M Buy
244,350
+164,054
+204% +$6.48M ﹤0.01% 2412
2018
Q1
$2.07M Buy
80,296
+49,179
+158% +$1.27M ﹤0.01% 3983
2017
Q4
$839K Buy
31,117
+4,173
+15% +$113K ﹤0.01% 4666
2017
Q3
$1.01M Buy
26,944
+15,382
+133% +$575K ﹤0.01% 4424
2017
Q2
$289K Buy
+11,562
New +$289K ﹤0.01% 5131